ML18025B099
| ML18025B099 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 01/23/2018 |
| From: | Northwest Medical Isotopes |
| To: | NRC/OGC |
| SECY RAS | |
| References | |
| 50-609-CP, Construction Permit Mndtry Hrg, RAS 54171 | |
| Download: ML18025B099 (15) | |
Text
1 Exhibit NWMI-004-R 1
Northwest Medical Isotopes, LLC Radioisotope Production Facility Overview January 23, 2018 U.S. Nuclear Regulatory Commission Commission Mandatory Meeting United States Nuclear Regulatory Commission Official Hearing Exhibit In the Matter of:
NORTHWEST MEDICAL ISOTOPES, LLC (Medical Radioisotope Production Facility)
Commission Mandatory Hearing Docket #: 05000609 Exhibit #:
Identified:
Admitted:
Withdrawn:
Rejected:
Stricken:
Other:
NWMI-004-R-MA-CM01 1/23/2018 1/23/2018
2 Exhibit NWMI-004-R NWMI Mission Fabricated Targets Irradiation services supplier 99Mo supplier Technetium generator supplier 99mTc supplier Irradiated targets Captive Network of University Research Reactors Reliability/assurance of supply Multiple shipments/week Radioisotope Production Facility (RPF)
Fabrication of LEU targets 99Mo production Uranium recycle and recovery
Domestic 99Mo Generator Distributors Hold FDA Drug Master File No changes to generators No changes to supply chain 99Mo Technetium generators 99mTc radiopharmaceuticals Assure a Domestic, Secure, and Reliable Supply of Molybdenum-99 (99Mo)
End User
3 Exhibit NWMI-004-R Primary Assumptions Single radioisotope production facility RPF
- RPF includes target fabrication, 99Mo production, and uranium recycle and recovery 99Mo produced by a fission-based method using LEU
- Nominal capacity 3,500 6-day curies (Ci); surge capacity of 1,500 6-day Ci Use network of university reactors
- Same target design used for all reactors
- Intellectual property obtained
- U.S., Australia, Russia, South Africa, Korea, Europe Allowed
- India, China Pending Fission product releases will comply with environmental release criteria Generate Class A, B, and C wastes; no greater than Class C (GTCC) waste
4 Exhibit NWMI-004-R Site Location and Description Site located within Discovery Ridge Research Park 550 acre
- University of Missouri (MU)-owned research park in Columbia - Boone County, Missouri Discovery Ridge located in central Missouri
- ~125 miles east of Kansas City and
~125 miles west of St. Louis
- 4.5 miles south of Interstate-70 and just to north of US Highway 63
- 3.5 miles to southeast of main MU campus
- 9.5 miles west of Missouri River RPF will be located on Lot 15 7.4-acre
- No existing structures
- Used for agriculture for past century NWMI anchor for radioisotope ecosystem; two existing companies
5 Exhibit NWMI-004-R Licensing Approach License Request: NWMI has submitted a Construction Permit Application to obtain a license for a production facility under Title 10, Code of Federal Regulations, Part 50 (10 CFR 50), Domestic Licensing of Production and Utilization Facilities
- Using guidance in NUREG-1537, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors - Format and Content Proposed Action: Issuance of an NRC license under 10 CFR 50 that would authorize NWMI to construct and operate a 99Mo RPF at a site located in Columbia, Missouri RPF will:
- Receive irradiated low-enriched uranium (LEU) targets (from a network of university research or test reactors)
- Process irradiated LEU targets for dissolution, recovery, and purification of 99Mo
- Recover and recycle LEU to minimize radioactive, mixed, and hazardous waste generation
- Treat/package wastes generated by RPF process steps to enable transport to a disposal site
- Provide areas for associated laboratory and other support activities
6 Exhibit NWMI-004-R Additional RPF Licensing Activities Additional RPF operational activities are subject to other NRC regulations
- 10 CFR 70, Domestic Licensing of Special Nuclear Material, to receive, possess, use, and transfer special nuclear material
- Producing LEU target materials and fabrication of targets
- 10 CFR 30, Rules of General Applicability to Domestic Licensing of Byproduct Material, to process and transport 99Mo for medical applications
- Handling of byproduct material University reactor(s) and cask licensee(s) will amend their current operating licenses
7 Exhibit NWMI-004-R Proposed Schedule (Calendar Year)
Start date of site preparation/construction Q2 2018 End date of construction Q3 2019 Start date of facility startup and cold commissioning (pre-operational) Q4 2019 Date of hot commissioning and commercial operations Q1 2020 Date of decommissioning: 2050
8 Exhibit NWMI-004-R RPF Operating Characteristics LEU target material is fabricated (both fresh LEU and recycled U)
LEU target material encapsulated using metal cladding LEU target LEU targets are packaged and shipped to university reactors for irradiation After irradiation, targets are shipped back to RPF Irradiated LEU targets disassembled Irradiated LEU targets dissolved into a solution for processing Dissolved LEU solution is processed to recover and purify 99Mo Purified 99Mo is packaged/shipped to a radiopharmaceutical distributor LEU solution is treated to recover U and is recycled back to Step 1 Irradiate Targets in Reactor LEU Target Material Production Encapsulation Irradiated Target Disassembly Target Dissolution Mo Recovery and Purification Uranium Recovery and Recycle Mo Product Packaging Fresh Blended Uranium Product Cask Shipments to Customer Unirradiated Target Shipping to University Reactors Irradiated Target Shipping and Receiving Purified U Solution Impure U Solution Purified 99Mo Solution Target Cladding to Solid Waste Handling Dissolved Targets Fission Product Solution to Liquid Waste Handling Offgas treatment and release to stack via Primary Ventilation Legend Reactor Operations RPF Operations Target Packaging
Target Fabrication 99Mo Production Irradiated Target Disassembly and Dissolution 2013-021_010r4
9 Exhibit NWMI-004-R RPF Operating Characteristics (continued)
Ventilation System
- Ventilation system will be divided into four zones (Zone I, Zone II, Zone III, and Zone IV) with airflow directed from lowest to highest potential for contamination
- Zone I ventilation system will be initial confinement barrier (e.g., gloveboxes, tank hot cell, processing hot cells, and Zone I exhaust subsystem)
Biological Shield
- Provides an integrated system of features that protects workers from high-dose radiation generated during facility operations
- Will withstand seismic and other concurrent loads, while maintaining containment and shielding during a design basis event
- Primary function is to reduce radiation dose rates and accumulated doses in occupied areas to not exceed limits of 10 CFR 20 and RPF ALARA guidelines program Engineered Safety Features (ESF)
- Active or passive features designed to mitigate consequences of accidents and to keep radiological exposures to workers, the public, and environment within acceptable values
- Confinement is considered a general ESF
10 Exhibit NWMI-004-R Reagent, Product, and Waste Summary Flow Diagram
11 Exhibit NWMI-004-R RPF Description
First level footprint ~52,000 square feet (ft2)
- Target fabrication area
- Hot cell processing area (dissolution, 99Mo, and 235U recovery)
- Waste management, laboratory, and utility areas
Basement ~2,000 ft2 (tank hot cell, decay vault)
Second level ~17,000 ft2 (utility, ventilation, offgas equipment)
Waste Management Building ~1,200 ft2
Administration Building (outside secured RPF area) ~10,000 ft2 High bay roof - 65 ft Mechanical area, second floor - 46 ft Top of exhaust stack - 75 ft Loading dock (back) roof - 20 ft Support and admin (front) roof - 12 ft Depth below grade for hot cell/high-integrity container (HIC) storage - 15 ft
12 Exhibit NWMI-004-R RPF Consequences and Radionuclide Inventory Summary Primary consequences resulting from operation of RPF operations are radiological
- LEU target material production/fabrication
- Irradiated LEU target material processing (e.g., extract 99Mo and recycle and recover 235U)
- Radioactive waste materials processing RPF radionuclide inventory is based on a weekly throughput of irradiated targets
- MURR 8 targets
- OSTR 30 targets Maximum radionuclide inventory is based on accumulation in various systems dependent on process material decay times
>100K Ci
>50K Ci
>10K Ci
<10K Ci Legend
< 40 hr EOI
> 40 hr EOI
13 Exhibit NWMI-004-R Transportation Fresh LEU
- ES-3100 package (Certificate of Compliance No. 9315)
Unirradiated targets
- ES-3100 or similar package Irradiated targets
- BEA Research Reactor cask or similar (Certificate of Compliance No. 9341)
99Mo product
- Medical Isotope Depleted Uranium Shielded (MIDUS) Type B(U) container (Certificate of Compliance USA/9320/B(U)-96)
Radioactive waste
- High-dose radioactive waste High integrity casks (e.g., Model 10-160B cask)
- Low-dose radioactive waste 208 liter (L) (55-gallon [gal]) waste drums Contact-handled waste
- Standard industrial waste drums or other appropriate [<2 millisievert (mSv)/hr (200 millirem [mrem]/hr) on contact and 0.1 mSv/hr (10 mrem/hr) at 1 meter (m) (3.3 ft)]
14 Exhibit NWMI-004-R Quality Assurance Program Plan NWMI Quality Assurance Program Plan (QAPP) describes policies and requirements necessary to meet applicable Federal regulations
- ANSI/ANS 15.8, Quality Assurance Program Requirements for Research Reactors
- Regulatory Guide 2.5, Quality Assurance Program Requirements for Research and Test Reactors
- 10 CFR 70.64(a)(1), Quality Standards and Records QAPP applies to all nuclear, quality-related projects and activities that require conformance to a nuclear quality assurance (QA) program NWMI RPF Organization
15 Exhibit NWMI-004-R Questions?